Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2010
10/21/2010WO2010097576A9 1, 4-disubstituted piperidines as vasopressin receptor via antagonists
10/21/2010WO2010077589A3 Stat3 inhibitors and therapeutic methods using the same
10/21/2010WO2009126515A8 Compounds and compositions as protein kinase inhibitors
10/21/2010US20100267964 N-heterocyclylphenyl-substituted cyclic ketoenols
10/21/2010US20100267952 Use of novel compound having affinity for amyloid, and process for production of the same
10/21/2010US20100267749 Trisubstituted furopyrimidines and use thereof
10/21/2010US20100267748 HETEROCYCLIC COMPOUNDS USEFUL AS STEAROYL CoA DESATURASE INHIBITORS
10/21/2010US20100267740 Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators - 842
10/21/2010US20100267739 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
10/21/2010US20100267730 Novel compounds
10/21/2010US20100267728 3-substituted-1,2,3-triazin-4-one's and 3 substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses
10/21/2010US20100267722 Novel proline derivatives
10/21/2010US20100267717 Novel Heterocyclic NF-kB Inhibitors
10/21/2010US20100267708 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
10/21/2010US20100267704 Autophagy Inducing Compounds and Uses Thereof in Treating Autophagy Associated Diseases
10/21/2010US20100267699 Chemical compounds - 643
10/21/2010US20100267696 Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors
10/21/2010US20100267692 smac mimetic compounds as apoptosis inducers
10/21/2010US20100267672 Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof
10/21/2010US20100267671 Compositions and methods for apoptosis modulators
10/21/2010US20100267666 Pyrrolopyrazine kinase inhibitors
10/21/2010US20100266509 Heteroaryl amide analogues as p2x7 antagonists
10/21/2010CA2758904A1 Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof
10/21/2010CA2758367A1 Derivatives of n-[(7-aza-bicyclo[2.2.1]hept-1-yl)-aryl-methyl]-benzamide, preparation thereof, and therapeutic use thereof
10/21/2010CA2756759A1 Imidazopyrazines for use as kinase inhibitors
10/20/2010EP2240497A1 Use of sulfonated dye salt for modulating dye stability
10/20/2010EP2240493A2 Antibiotic tetrahydro-beta-carboline derivatives
10/20/2010EP2240488A1 Substituted imidazopyridazines useful as kinase inhibitors
10/20/2010EP2240487A1 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments
10/20/2010EP2240486A1 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
10/20/2010EP2240485A1 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
10/20/2010EP2240484A1 Method of synthesizing tetrahydrobiopterin
10/20/2010EP2240483A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
10/20/2010EP2240454A1 Mesoionic pesticides
10/20/2010EP2240452A1 Certain chemical entities, compositions and methods
10/20/2010EP2240451A1 Certain chemical entities, compositions and methods
10/20/2010EP2240029A1 Compounds for inflammation and immune-related uses
10/20/2010EP2240028A1 Organic compounds
10/20/2010EP2114945B1 Pteridinone derivatives as pi3-kinases inhibitors
10/20/2010EP1984331B1 Pyrrolidine derivatives as erk inhibitors
10/20/2010EP1689751B1 5,7-diaminopyrazolo[4,3-d]pyrimidines with pde-5 inhibiting activity
10/20/2010EP1626973B1 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
10/20/2010CN101868461A Process for the synthesis of E1 activating enzyme inhibitors
10/20/2010CN101868458A Isoxazolo-pyridazine derivatives
10/20/2010CN101863892A Preparation mothod of epibatidine and analogues thereof
10/20/2010CN101863891A Trifluoromethane triazolidine quinoxaline derivative and preparation method thereof
10/20/2010CN101863890A Imidazole alkaloid extracted from Echinogorgia pseudossapo and preparation method and application thereof
10/20/2010CN101863886A Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/19/2010US7816673 Di-thieno-benzo-thieno-thiophene derivatives; heat treatment; improved solubility
10/19/2010US7816526 Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same
10/19/2010US7816518 Porphyrin derivatives and their use in photon activation therapy
10/19/2010US7816398 Fatty alcohol drug conjugates
10/19/2010US7816365 Amine derivatives
10/19/2010US7816360 MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
10/19/2010US7816357 Regulation of appetite, antiemetics, immunosuppression, analgesia, inflammation, antinocioception, sedation, and intraocular pressure; synergistic; 2-(4-(Trifluoromethyl)benzyl)-7,8-bis(4-chlorophenyl)-6-(methylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
10/19/2010US7816353 P70S6 kinase modulators and method of use
10/19/2010US7816350 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout
10/19/2010CA2458699C Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
10/19/2010CA2436589C Heterocyclic compounds and cognitive enhancers comprising the same as effective components
10/19/2010CA2393158C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/14/2010WO2010118367A2 Antiviral pyrimidines
10/14/2010WO2010118207A1 Pyrazolo [1, 5-a] pyrimidine derivatives as mtor inhibitors
10/14/2010WO2010117935A1 Compounds and methods for antiviral treatment
10/14/2010WO2010117787A2 Inhibiting eph b-3 kinase
10/14/2010WO2010117738A2 Solid state forms of sitagliptin salts
10/14/2010WO2010116594A1 Photoresist material, photoresist film, etching method using same, and novel azo dye compound
10/14/2010WO2010116177A1 A pyrazolo [4,5-e] pyrimidine derivative and its use to treat diabetes and obesity
10/14/2010WO2010116176A1 Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity
10/14/2010WO2010115767A1 Pyrrolopyrrole derivatives, their manufacture and use as semiconductors
10/14/2010WO2010115688A1 Anthelmintic agents and their use
10/14/2010WO2010115264A1 Inhibitors of hiv replication
10/14/2010WO2010083283A3 Processes for preparing jak inhibitors and related intermediate compounds
10/14/2010WO2010077680A3 Compositions of protein receptor tyrosine kinase inhibitors
10/14/2010WO2010068838A3 PROCESSES FOR PREPARING 5,7 DIAMINOPYRAZOLO[1,5-α] PYRIMIDINE COMPOUNDS
10/14/2010WO2010066684A3 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
10/14/2010WO2010057104A3 Pyridoindole modulators of nmda receptor and acetylcholinesterase
10/14/2010US20100261736 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular disease
10/14/2010US20100261733 Therapeutic agents 927
10/14/2010US20100261724 Heterocycle phenyl amide t-type calcium channel antagonists
10/14/2010US20100261710 HDAC Inhibitors
10/14/2010US20100261704 Therapeutic agents 928
10/14/2010US20100261683 Selective Inhibitors for Cyclin-Dependent Kinases
10/14/2010US20100261641 Spiro-piperidine compounds and medicinal use thereof
10/14/2010CA2758149A1 Inhibitors of hiv replication
10/14/2010CA2757241A1 Solid state forms of sitagliptin salts
10/14/2010CA2755669A1 Anthelmintic agents and their use
10/13/2010EP2239320A1 Nerve trunk cell propagation accelerator
10/13/2010EP2239263A1 Cyclic compound, its metal complex, and modified metal complex
10/13/2010EP2239262A2 Fused ring heterocycle kinase modulators
10/13/2010EP2239261A1 Pyrrolopyrimidin derivative for use as pi3k inhibitor, and use thereof
10/13/2010EP2238178A2 Photolatent amidine bases for redox curing of radically curable formulations
10/13/2010EP2238142A2 Macrocyclic indoles as hepatitis c virus inhibitors
10/13/2010EP2238141A1 Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of gsk3-beta
10/13/2010EP2238140A2 Substituted heteroarylamide diazepinopyrimidone derivatives
10/13/2010EP2238074A2 Fluoride processing method
10/13/2010EP1480644B1 Novel heterocyclic compounds which are active as inhibitors of beta+lactamases
10/13/2010CN1910188B Use of phthalocyanines as marking substances for liquids
10/13/2010CN1886197B Pentasil-structuer zeolithic material, the production and use thereof
10/13/2010CN101861321A Pyrrolo [2, 3 -D] pyrimidin derivatives as protein kinase B inhibitors
10/13/2010CN101861320A Methods for preparing capecitabine and beta-anomer-rich trialkyl carbonate compound used therein
1 ... 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 ... 573